Protagonist Therapeutics (NASDAQ:PTGX) advances peptide-based research as nasdaq futures shape biotech discussions.

Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with ...

Signing season continues as some of the top athletes in the state put pen to paper and officially commit to their respective ...

EVs dominated the circular battery economy, accounting for 53% (USD 12.3 billion) of the 2024 market. The rapid expansion of ...

Which type of steel should you use? Alloy or carbon? This analysis explores both, highlighting their unique properties and ...

Energy-efficient frontal polymerization process eliminates the need of oven or autoclave to transform 2D printed structures ...

Sacituzumab tirumotecan demonstrated a 31% objective response rate and 71% disease control rate in advanced urothelial ...

Probable Lineup: Claire Robinson (jr., 9.3 ppg); Sydney Wittbrodt (jr.); Khloe Schmidt (soph.); Olivia Jo Rytlewski (fr.); ...

The UAE Ministry of Education has set out a series of regulatory requirements for the make-up examinations of the first ...

The Monticello girls basketball team made the leap from Class 3A to 4A this winter, and after an 0–2 start, the Magic secured ...

That said, several key categories of biomarkers can provide meaningful insight into long-term health.

AIKEN — The South Aiken girls may be young, but they were mighty against Strom Thurmond to remain undefeated early in the ...